BioRestorative Therapies ... (BRTX)
1.81
0.00 (0.00%)
At close: Jan 15, 2025, 3:59 PM
1.80
-0.55%
After-hours Jan 15, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| Net Income | -10.42M | -18.49M | -44.30M | -11.27M | -14.65M | -12.52M | -9.44M | -8.64M | -7.92M | -5.59M | -5.75M | -6.54M | -4.07M | -2.26M |
| Depreciation & Amortization | 165.74K | 120.55K | 89.11K | 121.38K | 217.36K | 240.37K | 259.26K | 258.43K | 213.78K | 96.69K | 104.81K | 90.40K | 90.41K | 48.36K |
| Stock-Based Compensation | 7.78M | 12.61M | 23.11M | 691.70K | 1.66M | 2.40M | 3.60M | 2.54M | 1.95M | 1.36M | 812.65K | 1.85M | 456.83K | 895.61K |
| Other Working Capital | 496.84K | -94.93K | 380.71K | 472.72K | 22.10K | -9.07M | 12.08K | -5.78M | -164.35K | 118.45K | -7.26M | 4.42K | 163.78K | 326.96K |
| Other Non-Cash Items | -4.48M | -123.54K | 1.27M | 5.12M | 4.21M | 3.17M | 926.45K | 570.21K | 114.42K | 50.03K | 224.31K | 2.18M | 283.54K | 1.08M |
| Deferred Income Tax | n/a | n/a | 16.18M | 2.80M | 1.11M | 1.65M | -17.00K | 87.27K | 460.21K | 371.15K | 412.73K | -1.81M | n/a | -895.61K |
| Change in Working Capital | 515.33K | 14.14K | 324.69K | 572.35K | 539.85K | -45.78K | 821.33K | 180.93K | 2.06M | 481.60K | 1.52M | 1.04M | 432.30K | 408.88K |
| Operating Cash Flow | -6.43M | -5.87M | -3.33M | -1.96M | -6.92M | -5.10M | -3.85M | -5.00M | -3.12M | -3.23M | -2.67M | -3.18M | -2.81M | -729.22K |
| Capital Expenditures | -171.04K | -440.22K | -30.66K | n/a | -35.63K | -12.87K | -3.62K | -188.76K | -483.07K | -168.38K | -11.16K | -1.00M | -17.77K | -48.78K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -17.54M | -13.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 20.96M | 9.49M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -13.13M | n/a | n/a | n/a | n/a | n/a | n/a | -75.00K | 980.00 | n/a | -1,000.00K | 32.00K | n/a |
| Investing Cash Flow | 3.25M | -13.48M | -30.66K | n/a | -35.63K | -12.87K | -3.62K | -188.76K | -483.07K | -167.40K | -11.16K | -1.00M | 14.23K | -48.78K |
| Debt Repayment | n/a | n/a | 250.00K | 5.52M | 5.18M | 4.19M | 2.21M | 1.42M | 1.21M | 592.94K | 1.45M | 2.19M | 2.65M | 155.86K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.00K | -28.00K |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | n/a | n/a | -490.00K | n/a | 414.17K | 981.25K | 140.87K | 441.17K | 88.01K | 530.80K | n/a | n/a | 1.88K |
| Financial Cash Flow | 2.35M | n/a | 21.32M | 5.03M | 6.84M | 4.78M | 4.28M | 5.06M | 3.68M | 3.29M | 2.88M | 4.12M | 2.85M | 796.03K |
| Net Cash Flow | -829.39K | -19.35M | 17.96M | 3.06M | -115.86K | -334.16K | 419.86K | -134.73K | 74.76K | -109.30K | 200.74K | -71.14K | 53.43K | 18.03K |
| Free Cash Flow | -6.60M | -6.31M | -3.36M | -1.96M | -6.95M | -5.12M | -3.86M | -5.19M | -3.61M | -3.40M | -2.68M | -4.19M | -2.83M | -778.00K |